In this episode, we’re joined by John Auerbach, senior vice president of federal health at consulting firm ICF. He discusses rising preeclampsia rates and how stakeholders need to act.
In this episode, we’re joined by Millicent Gorham, CEO of the Alliance for Women’s Health and Prevention (AWHP). AWHP recently launched the EveryBODY Covered campaign, which is advocating for comprehensive coverage of obesity care. Gorham discusses the current state of obesity treatment for women and her goals for the campaign.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In this episode, we’re joined by Régine Sitruk-Ware, a distinguished scientist at the Population Council’s Center for Biomedical Research (CBR), and Chelsea Polis, senior scientist of epidemiology at CBR. They talk about the effect upcoming male birth control products could have on women's health.
In this episode, we’re joined by Dr. Bruce Dorr, an OB-GYN. Dorr discusses how the lack of medical training for menopause has led to insufficient treatment.
In this episode, we're joined by Marielle Farina, senior manager of Deloitte. She's here to discuss a report she recently co-authored that found that employed women pay significantly more in out-of-pocket medical costs than employed men.
In this episode, we're joined by Melissa Tran, a marriage and family therapist and the military sexual trauma coordinator at the Orlando VA. She's here to discuss the unique challenges female veterans face and the programs she's helping build for this population.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
In this episode, we discuss SCAN Health Plan's recent launch of SCAN Inspired, a Medicare Advantage plan designed for women.
MedCity News is launching a new podcast called MedCity FemFwd, which will discuss the breakthroughs and challenges in the women's health space. In the inaugural episode, Michelle Long of KFF examines whether Opill — the first daily oral contraceptive approved for nonprescription use in the U.S. — will be covered by insurance.